Lantheus Medical Imaging clinical trials

A subsidiary of Lantheus Holdings, Inc.

The registry lists 30 studies whose lead sponsor is Lantheus Medical Imaging. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 21, 2026.

Studies

Recruiting first, then most recently updated. Showing 30 of 30. All Lantheus Holdings, Inc. studies →

• Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])RecruitingNCT07831824Phase 2/3

  Sponsor listed in the registry: Lantheus Medical Imaging

• Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)RecruitingNCT07357519Phase 1/2

  Sponsor listed in the registry: Lantheus Medical Imaging

• 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract CancerRecruitingNCT06298916Phase 1/2

  Sponsor listed in the registry: Lantheus Medical Imaging

• An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate CancerActive, not recruitingNCT05712473

  Sponsor listed in the registry: Lantheus Medical Imaging

• Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCCWithdrawnNCT07084909Phase 2/3

  Sponsor listed in the registry: Lantheus Medical Imaging

• PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate CancerActive, not recruitingNCT06074510Phase 4

  Sponsor listed in the registry: Lantheus Medical Imaging

• Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)Temporarily not availableNCT06033001

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary DiseaseCompletedNCT00162370Phase 4

  Sponsor listed in the registry: Lantheus Medical Imaging

• DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITYCompletedNCT03719612Phase 3

  Sponsor listed in the registry: Lantheus Medical Imaging

• DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITYCompletedNCT03571672Phase 3

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery PressureCompletedNCT00918866Phase 4

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical PracticeCompletedNCT00625365Phase 4

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.CompletedNCT01347710Phase 3

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart FailureCompletedNCT00891241Phase 1

  Sponsor listed in the registry: Lantheus Medical Imaging

• Study of [3H] BMS747158 in Healthy Male SubjectsCompletedNCT00930631Phase 1

  Sponsor listed in the registry: Lantheus Medical Imaging

• Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Echocardiography With or Without DEFINITY®CompletedNCT01299649

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at StressCompletedNCT00707538Phase 1

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158CompletedNCT00707499Phase 1

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki DiseaseCompletedNCT00162032Phase 3

  Sponsor listed in the registry: Lantheus Medical Imaging

• Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158CompletedNCT00849108Phase 2

  Sponsor listed in the registry: Lantheus Medical Imaging

• Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator FiringWithdrawnNCT01085175Phase 2

  Sponsor listed in the registry: Lantheus Medical Imaging

• Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MRCompletedNCT01135316

  Sponsor listed in the registry: Lantheus Medical Imaging

• Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPIWithdrawnNCT01681524Phase 3

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)WithdrawnNCT01085162

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Phase II Study of DMP 115 to Assess Focal Liver LesionsCompletedNCT00162058Phase 2

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric SubjectsCompletedNCT00162045Phase 1/2

  Sponsor listed in the registry: Lantheus Medical Imaging

• DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart FunctionCompletedNCT00401687Phase 4

  Sponsor listed in the registry: Lantheus Medical Imaging

• A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.CompletedNCT00162344Phase 4

  Sponsor listed in the registry: Lantheus Medical Imaging

• CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MICompletedNCT00162331Phase 4

  Sponsor listed in the registry: Lantheus Medical Imaging

• Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by AngioplastyCompletedNCT00162357Phase 4

  Sponsor listed in the registry: Lantheus Medical Imaging